An optimization strategy on prion AGAAAAGA amyloid fibril molecular modeling

TL;DR

This paper presents a novel optimization strategy to model the 3D atomic structure of prion AGAAAAGA amyloid fibrils, addressing the lack of structural data due to experimental limitations.

Contribution

The study introduces a simple optimization approach for modeling prion amyloid fibrils at atomic resolution, filling a gap in structural data for this protein region.

Findings

Successfully modeled the 3D structure of prion AGAAAAGA amyloid fibrils.

Provides structural insights useful for prion disease treatment research.

Offers a computational method applicable to insoluble, noncrystalline proteins.

Abstract

X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy are two powerful tools to determine the protein 3D structure. However, not all proteins can be successfully crystallized, particularly for membrane proteins. Although NMR spectroscopy is indeed very powerful in determining the 3D structures of membrane proteins, same as X-ray crystallography, it is still very time-consuming and expensive. Under many circumstances, due to the noncrystalline and insoluble nature of some proteins, X-ray and NMR cannot be used at all. Computational approaches, however, allow us to obtain a description of the protein 3D structure at a submicroscopic level. To the best of the author's knowledge, there is little structural data available to date on the AGAAAAGA palindrome in the hydrophobic region (113--120) of prion proteins, which falls just within the N-terminal unstructured region (1--123) of prion proteins. Many experimental studies have shown that the AGAAAAGA region has amyloid fibril forming properties and plays an important role in prion diseases. However, due to the noncrystalline and insoluble nature of the amyloid fibril, little structural data on the AGAAAAGA is available. This paper introduces a simple optimization strategy approach to address the 3D atomic-resolution structure of prion AGAAAAGA amyloid fibrils. Atomic-resolution structures of prion AGAAAAGA amyloid fibrils got in this paper are useful for the drive to find treatments for prion diseases in the field of medicinal chemistry.